Wataru Yamamoto

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Clinical Evaluation

Rheumatoid Arthritis

Disease Activity

Interstitial Lung Disease

Top Venues

Rheumatology international

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Kosuke Ebina, Yuki Etani, Yuichi Maeda, Yasutaka Okita, Makoto Hirao, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Ryota Hara, Koji Nagai, Yuri Hiramatsu, Yonsu Son, Hideki Amuro, Takayuki Fujii, Takaichi Okano, Yo Ueda, Masaki Katayama, Tadashi Okano, Shotaro Tachibana, Tomoyuki Kamenaga, Atsushi Kumanogoh, Seiji Okada, Ken Nakata
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study. RMD open 9 (3) (2023)
Yoichi Nakayama, Ryu Watanabe, Kosaku Murakami, Koichi Murata, Masao Tanaka, Hiromu Ito, Wataru Yamamoto, Kosuke Ebina, Kenichiro Hata, Yuri Hiramatsu, Masaki Katayama, Yonsu Son, Hideki Amuro, Kengo Akashi, Akira Onishi, Ryota Hara, Keiichi Yamamoto, Koichiro Ohmura, Shuichi Matsuda, Akio Morinobu, Motomu Hashimoto
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study. Rheumatology international 42 (7) (2022)
Tomoya Nakajima, Ryu Watanabe, Motomu Hashimoto, Koichi Murata, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Wataru Yamamoto, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Koichiro Ohmura, Shuichi Matsuda, Akio Morinobu
Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients. Rheumatology international (2021)
Hiroto Minamino, Masao Katsushima, Motomu Hashimoto, Yoshihito Fujita, Mie Torii, Kaori Ikeda, Nozomi Isomura, Yasuo Oguri, Wataru Yamamoto, Ryu Watanabe, Kosaku Murakami, Koichi Murata, Kohei Nishitani, Masao Tanaka, Hiromu Ito, Miyabi Uda, Kazuko Nin, Hidenori Arai, Shuichi Matsuda, Akio Morinobu, Nobuya Inagaki
Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database. PloS one 16 (8) (2021)
Kosuke Ebina, Toru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Akira Onishi, Sadao Jinno, Ryota Hara, Yonsu Son, Hideki Amuro, Tohru Takeuchi, Ayaka Yoshikawa, Masaki Katayama, Keiichi Yamamoto, Makoto Hirao, Yasutaka Okita, Atsushi Kumanogoh, Ken Nakata
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study. Clinical rheumatology 40 (7) (2021)
Yuichi Maeda, Toru Hirano, Kosuke Ebina, Ryota Hara, Motomu Hashimoto, Wataru Yamamoto, Kosaku Murakami, Takuya Kotani, Kenichiro Hata, Yonsu Son, Hideki Amuro, Akira Onishi, Sadao Jinno, Masaki Katayama, Atsushi Kumanogoh
Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study. Rheumatology international 41 (7) (2021)
Kosuke Ebina, Toru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Tohru Takeuchi, Koji Nagai, Yonsu Son, Hideki Amuro, Akira Onishi, Sadao Jinno, Ryota Hara, Masaki Katayama, Keiichi Yamamoto, Atsushi Kumanogoh, Makoto Hirao
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study. Clinical rheumatology 39 (9) (2020)
Hiroto Minamino, Masao Katsushima, Tamami Yoshida, Motomu Hashimoto, Yoshihito Fujita, Mirei Shirakashi, Wataru Yamamoto, Kosaku Murakami, Koichi Murata, Kohei Nishitani, Masao Tanaka, Hiromu Ito, Nobuya Inagaki, Shuichi Matsuda
Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database. PloS one 15 (3) (2020)
Sadao Jinno, Akira Onishi, M Hassan Murad, Kengo Akashi, Motomu Hashimoto, Wataru Yamamoto, Koichi Murata, Tohru Takeuchi, Takuya Kotani, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Jun Saegusa, Akio Morinobu
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study. Rheumatology international 40 (12) (2020)
Koichi Murata, Motomu Hashimoto, Wataru Yamamoto, Yonsu Son, Hideki Amuro, Koji Nagai, Tohru Takeuchi, Masaki Katayama, Yuichi Maeda, Kosuke Ebina, Ryota Hara, Sadao Jinno, Akira Onishi, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Tsuneyo Mimori, Shuichi Matsuda
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatology international 40 (2) (2019)
Tamami Yoshida, Motomu Hashimoto, Rie Kawahara, Hiroko Yamamoto, Masao Tanaka, Hiromu Ito, Izuru Masuda, Kiminori Hosoda, Wataru Yamamoto, Ryuji Uozumi, Satoshi Morita, Yasutomo Fujii, Tsuneyo Mimori, Kazuko Nin
Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology international 38 (9) (2018)